It said Abcellute Tissue Bank, a subsidiary of Abcellute Holdings, was already working with a number of NHS Trusts to supply fresh tissue and cells to the global pharmaceutical industry and research organisations.

It said the launch of the new tissue bank would enable Abcellute to offer a broader range of tissues to supplement its product portfolio.

Abcellute Holdings recently completed a £220,000 funding round that will enable Abcellute to apply its proprietary transport media to human cells giving researchers across the globe access to this precious and vital resource to drug development.

Fusion IP and Finance Wales each invested £110,000 in the round, taking their shareholdings to 32% and 22% respectively.

Story provided by Business Financial Newswire